La CT funciona activando las proteínas GGs y Gq que a menudo se encuentran en los osteoclastos, en las células del riñón y en las células de varias regiones del cerebro.[5] También puede afectar los ovarios en las mujeres y los testículos en los hombres.
La función de la proteína del receptor CT se modifica a través de su interacción con las proteínas modificadoras de la actividad del receptor(RAMPs), formando los receptores de amilina multimérica AMY1 (CT + RAMP1), AMY2 (CT + RAMP2), y AMY3 (CT + RAMP3).[6]
↑«senselab». Archivado desde el original el 28 de febrero de 2009. Consultado el 20 de abril de 2019.
↑«Calcitonin Receptors: Introduction». IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Archivado desde el original el 3 de marzo de 2016.
↑Zhang J, Herscovitz H. (February 2003). «Nascent lipidated apolipoprotein B is transported to the Golgi as an incompletely folded intermediate as probed by its association with network of endoplasmic reticulum molecular chaperones, GRP94, ERp72, BiP, calreticulin, and cyclophilin B». The Journal of Biological Chemistry278 (9): 7459-68. PMID12397072. doi:10.1074/jbc.M207976200.
↑Linnik KM, Herscovitz H. (August 1998). «Multiple molecular chaperones interact with apolipoprotein B during its maturation. The network of endoplasmic reticulum-resident chaperones (ERp72, GRP94, calreticulin, and BiP) interacts with apolipoprotein b regardless of its lipidation state». The Journal of Biological Chemistry273 (33): 21368-73. PMID9694898. doi:10.1074/jbc.273.33.21368.
Albrandt K, Brady EM, Moore CX, Mull E, Sierzega ME, Beaumont K (December 1995). «Molecular cloning and functional expression of a third isoform of the human calcitonin receptor and partial characterization of the calcitonin receptor gene». Endocrinology136 (12): 5377-84. PMID7588285. doi:10.1210/en.136.12.5377.
Egerton M, Needham M, Evans S, Millest A, Cerillo G, McPheat J, Popplewell M, Johnstone D, Hollis M (April 1995). «Identification of multiple human calcitonin receptor isoforms: heterologous expression and pharmacological characterization». Journal of Molecular Endocrinology14 (2): 179-89. PMID7619207. doi:10.1677/jme.0.0140179.
Nussenzveig DR, Mathew S, Gershengorn MC (May 1995). «Alternative splicing of a 48-nucleotide exon generates two isoforms of the human calcitonin receptor». Endocrinology136 (5): 2047-51. PMID7720653. doi:10.1210/en.136.5.2047.
Nakamura M, Hashimoto T, Nakajima T, Ichii S, Furuyama J, Ishihara Y, Kakudo K (April 1995). «A new type of human calcitonin receptor isoform generated by alternative splicing». Biochemical and Biophysical Research Communications209 (2): 744-51. PMID7733946. doi:10.1006/bbrc.1995.1562.
Pérez Jurado LA, Li X, Francke U (1995). «The human calcitonin receptor gene (CALCR) at 7q21.3 is outside the deletion associated with the Williams syndrome». Cytogenetics and Cell Genetics70 (3-4): 246-9. PMID7789182. doi:10.1159/000134044.
Nussenzveig DR, Thaw CN, Gershengorn MC (November 1994). «Inhibition of inositol phosphate second messenger formation by intracellular loop one of a human calcitonin receptor. Expression and mutational analysis of synthetic receptor genes». The Journal of Biological Chemistry269 (45): 28123-9. PMID7961748.
Kuestner RE, Elrod RD, Grant FJ, Hagen FS, Kuijper JL, Matthewes SL, O'Hara PJ, Sheppard PO, Stroop SD, Thompson DL (August 1994). «Cloning and characterization of an abundant subtype of the human calcitonin receptor». Molecular Pharmacology46 (2): 246-55. PMID8078488.
Frendo JL, Pichaud F, Mourroux RD, Bouizar Z, Segond N, Moukhtar MS, Jullienne A (April 1994). «An isoform of the human calcitonin receptor is expressed in TT cells and in medullary carcinoma of the thyroid». FEBS Letters342 (2): 214-6. PMID8143880. doi:10.1016/0014-5793(94)80503-2.
Masi L, Becherini L, Gennari L, Colli E, Mansani R, Falchetti A, Cepollaro C, Gonnelli S, Tanini A, Brandi ML (April 1998). «Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women». Biochemical and Biophysical Research Communications245 (2): 622-6. PMID9571205. doi:10.1006/bbrc.1998.8445.
Taboulet J, Frenkian M, Frendo JL, Feingold N, Jullienne A, de Vernejoul MC (December 1998). «Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women». Human Molecular Genetics7 (13): 2129-33. PMID9817931. doi:10.1093/hmg/7.13.2129.
Christopoulos G, Perry KJ, Morfis M, Tilakaratne N, Gao Y, Fraser NJ, Main MJ, Foord SM, Sexton PM (July 1999). «Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product». Molecular Pharmacology56 (1): 235-42. PMID10385705.
Nishikawa T, Ishikawa H, Yamamoto S, Koshihara Y (September 1999). «A novel calcitonin receptor gene in human osteoclasts from normal bone marrow». FEBS Letters458 (3): 409-14. PMID10570950. doi:10.1016/S0014-5793(99)01176-X.
Beaudreuil J, Taboulet J, Orcel P, Graulet AM, Denne MA, Baudoin C, Jullienne A, De Vernejoul MC (July 2000). «Calcitonin receptor mRNA in mononuclear leucocytes from postmenopausal women: decrease during osteoporosis and link to bone markers with specific isoform involvement». Bone27 (1): 161-8. PMID10865224. doi:10.1016/S8756-3282(00)00305-7.
Wada S, Yasuda S, Nagai T, Maeda T, Kitahama S, Suda S, Findlay DM, Iitaka M, Katayama S (April 2001). «Regulation of calcitonin receptor by glucocorticoid in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor». Endocrinology142 (4): 1471-8. PMID11250927. doi:10.1210/en.142.4.1471.
Nosaka Y, Tachi Y, Shimpuku H, Kawamura T, Ohura K (2002). «Association of calcitonin receptor gene polymorphism with early marginal bone loss around endosseous implants». The International Journal of Oral & Maxillofacial Implants17 (1): 38-43. PMID11858573.
Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, Wagner L, Shenmen CM, Schuler GD, Altschul SF, Zeeberg B, Buetow KH, Schaefer CF, Bhat NK, Hopkins RF, Jordan H, Moore T, Max SI, Wang J, Hsieh F, Diatchenko L, Marusina K, Farmer AA, Rubin GM, Hong L, Stapleton M, Soares MB, Bonaldo MF, Casavant TL, Scheetz TE, Brownstein MJ, Usdin TB, Toshiyuki S, Carninci P, Prange C, Raha SS, Loquellano NA, Peters GJ, Abramson RD, Mullahy SJ, Bosak SA, McEwan PJ, McKernan KJ, Malek JA, Gunaratne PH, Richards S, Worley KC, Hale S, Garcia AM, Gay LJ, Hulyk SW, Villalon DK, Muzny DM, Sodergren EJ, Lu X, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madan A, Young AC, Shevchenko Y, Bouffard GG, Blakesley RW, Touchman JW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Krzywinski MI, Skalska U, Smailus DE, Schnerch A, Schein JE, Jones SJ, Marra MA (December 2002). «Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences». Proceedings of the National Academy of Sciences of the United States of America99 (26): 16899-903. PMC139241. PMID12477932. doi:10.1073/pnas.242603899.
«Calcitonin Receptors». IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Consultado el 5 de diciembre de 2023.